Skip to main content

Opioid Settlements

The Vermont Attorney General’s Office has been fighting to end the opioid crisis and hold industry participants accountable for their roles in promoting and profiting from the opioid epidemic. 


As a result of Vermont Attorney General’s efforts, both individually and together with other State Attorneys General, 2021 settlements were reached against the three largest pharmaceutical distributors, McKesson, Cardinal Health and Amerisource Bergen (“Distributors”), and drug manufacture Janssen Pharmaceuticals, Inc., and its parent company Johnson & Johnson (J&J).

Linked below are an Executive Summary of the settlements, the Settlement Agreements, and key exhibits to the two settlement agreements.

Executive Summary

Distributor Settlement Agreement

Janssen (J&J) Settlement Agreement

Exhibit E - List of Opioid Remediation Uses

Exhibit G - Qualified Subdivisions List

Exhibit K - Subdivision Settlement Participation Form



In 2022, settlements were also reached with drug manufacturers Teva and Allergan and pharmacy chains Walgreens, Walmart, and CVS.

The 2022 Settlement Agreements and related Opioids Settlement Information for Subdivisions are linked below. Exhibits E, G, and K are the same for the settlements with Teva, Allergan, Walgreens, Walmart, and CVS as for the Distributors and Janssen.


Opioids Settlement Information for Subdivisions

Teva Settlement Agreement

Allergan Settlement Agreement

CVS Settlement Agreement

Walgreens Settlement Agreement

Walmart Settlement Agreement


Additional information about all opioids settlements may be found at:

The amounts of past and future annual payments to Vermont and each city, town, and county from the Distributors and Janssen settlements are available here:

Similar information is not yet available for the settlements with Teva, Allergan or the chain pharmacies. It is expected that payments to Vermont from those settlements will begin during summer 2024.